Apolipoprotein A1 Infusions and Cardiovascular Outcomes after Acute Myocardial Infarction
2024 · New England Journal of Medicine · 103 citations
https://doi.org/10.1056/nejmoa2400969
M
Mark Heise
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
44
Papers
5.0K
Citations
19
h-index
21
i10-index
Mark Heise is an academic researcher from CSL (United States). The author has contributed to research in topics: Diabetes Treatment and Management & Metabolism, Diabetes, and Cancer & Peroxisome Proliferator-Activated Receptors. The author has an h-index of 19, co-authored 38 publications.
ORCID: 0009-0002-6064-0280Papers by this author
worksIL-6 inhibition with clazakizumab in patients receiving maintenance dialysis: a randomized phase 2b trial
2024 · Nature Medicine · 63 citations
https://doi.org/10.1038/s41591-024-03043-1
Effect of Reconstituted Human Apolipoprotein A-I on Recurrent Ischemic Events in Survivors of Acute MI
2024 · Journal of the American College of Cardiology · 28 citations
https://doi.org/10.1016/j.jacc.2024.03.396
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat